Literature DB >> 21969264

FMR1 and the continuum of primary ovarian insufficiency.

Shannon D Sullivan1, Corrine Welt, Stephanie Sherman.   

Abstract

Spontaneous 46,XX primary ovarian insufficiency (POI) is a term that describes ovarian dysfunction resulting in a range of abnormalities, from infertility to early menopause as the end stage (overt POI). The most common known genetic cause of 46,XX POI is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene. This "premutation" is associated with overt POI (FXPOI) in ~20% of carrier women. Greater than 200 CGG copies results in methylation of the CGG repeats and subsequent silencing of the FMR1 gene, causing fragile X syndrome. This "full" mutation is not associated with FXPOI. Even in the absence of overt FXPOI, women who carry the premutation may exhibit ovarian dysfunction along a continuum of severity. Evidence also suggests that the severity of FXPOI depends on the CGG repeat length, background modifier genes, and environmental factors (e.g., smoking). This review explores the range of ovarian dysfunction, the mechanisms behind the dysfunction, and the reasons for the variability in presentation in women who carry the FMR1 premutation. Understanding the mechanisms responsible for development of FXPOI is paramount to providing these women with the best overall health care. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969264     DOI: 10.1055/s-0031-1280915

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  68 in total

1.  Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus.

Authors:  J Kline; A Kinney; S Brown; B Levin; K Oppenheimer; D Warburton
Journal:  Hum Reprod       Date:  2012-04-06       Impact factor: 6.918

Review 2.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

3.  The insectan apes.

Authors:  Bernard Crespi
Journal:  Hum Nat       Date:  2014-03

4.  Newborn screening and cascade testing for FMR1 mutations.

Authors:  Page L Sorensen; Louise W Gane; Mark Yarborough; Randi J Hagerman; Flora Tassone
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

Review 5.  The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology.

Authors:  Jim Grigsby
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

6.  Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.

Authors:  Igor Albizua; Benjamin L Rambo-Martin; Emily G Allen; Weiya He; Ashima S Amin; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

7.  Climbing the branches of a family tree: diagnosis of fragile X syndrome.

Authors:  Jeannie Visootsak; Heather Hipp; Heather Clark; Elizabeth Berry-Kravis; Tovi Anderson; Dawn Laney
Journal:  J Pediatr       Date:  2014-03-06       Impact factor: 4.406

Review 8.  Fertility counseling and preservation: considerations for the pediatric endocrinologist.

Authors:  Amanda J Saraf; Leena Nahata
Journal:  Transl Pediatr       Date:  2017-10

9.  BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study.

Authors:  Efrat Dagan; Yoram Cohen; Adi Mory; Vardit Adir; Zvi Borochowitz; Hila Raanani; Alina Kurolap; Svetlana Melikhan-Revzin; Dror Meirow; Ruth Gershoni-Baruch
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

10.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.